Search

Your search keyword '"Standish, Barry"' showing total 8 results
Start Over Author "Standish, Barry" Topic depressive disorder
8 results on '"Standish, Barry"'

1. Does lithium reduce the mortality of recurrent mood disorders?

Author

Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, and Hermon C

Subjects
Bipolar Disorder psychology, Cross-Sectional Studies, Depressive Disorder psychology, England epidemiology, Follow-Up Studies, Humans, Incidence, Psychotic Disorders psychology, Recurrence, Suicide psychology, Wales epidemiology, Bipolar Disorder drug therapy, Bipolar Disorder mortality, Cause of Death, Depressive Disorder drug therapy, Depressive Disorder mortality, Lithium Carbonate therapeutic use, Psychotic Disorders drug therapy, Psychotic Disorders mortality, Suicide statistics & numerical data, Suicide Prevention
Abstract

Numerous follow-up studies have shown that patients with mood disorders who do not receive prophylactic medication are at increased risk of death, particularly from suicide. After 11 years follow-up we compared the mortality of 103 patients attending a lithium clinic with that expected on the basis of age/sex/year-specific rates for England and Wales. Only 10 patients died during the study, although the expected number of deaths was 18.31 (P = 0.052, two-tailed) and no deaths from suicide were observed. After correcting for the prevalence of mood disorder in the general population, the relative risk was 0.60 (95% CI 0.29-1.12) which suggests that lithium reverses the excess mortality associated with recurrent mood disorders, including that from suicide.

Published
1991
Full Text
View/download PDF

2. Treating refractory depression.

Author

Standish-Barry H

Subjects
Aged, Antidepressive Agents administration & dosage, Chronic Disease, Combined Modality Therapy, Dose-Response Relationship, Drug, Frontal Lobe surgery, Humans, Psychosurgery, Bipolar Disorder therapy, Depressive Disorder therapy
Published
1990

3. Ventricular size and CSF transmitter metabolite concentrations in severe endogenous depression.

Author

Standish-Barry HM, Bouras N, Hale AS, Bridges PK, and Bartlett JR

Subjects
Adult, Aged, Depressive Disorder blood, Depressive Disorder cerebrospinal fluid, Female, Humans, Male, Middle Aged, Cerebral Ventricles pathology, Depressive Disorder pathology, Hydroxyindoleacetic Acid cerebrospinal fluid, Neurotransmitter Agents metabolism, Tryptophan blood
Abstract

The relationship between neurotransmitter metabolite concentrations and measurements of ventricular size on CAT scans and pneumoencephalographs was investigated in 15 patients with severe affective disorder. An association was identified between reduced levels of plasma free tryptophan and ventricular enlargement, and also between raised ventricular CSF levels of 5 HIAA and ventricular enlargement.

Published
1986
Full Text
View/download PDF

4. The relationship of concurrent benzodiazepine administration to seizure duration in ECT.

Author

Standish-Barry HM, Deacon V, and Snaith RP

Subjects
Adult, Combined Modality Therapy, Depressive Disorder drug therapy, Diazepam therapeutic use, Female, Humans, Male, Middle Aged, Time Factors, Depressive Disorder therapy, Diazepam pharmacology, Electroconvulsive Therapy
Abstract

The relationship of concurrent benzodiazepine administration to seizure duration in ECT was examined. Administration of a standard oral dose of 10 mg diazepam to a series of patients suffering from major depressive disorder produced a significant reduction in men seizure length during ECT compared to length of ECT-induced seizure in those patients when they were benzodiazepine free. This finding is discussed.

Published
1985
Full Text
View/download PDF

5. Does lithium reduce the mortality of recurrent mood disorders?

Author

C Hermon, J. Bailey, H. Standish-Barry, G. Houston, P. Silcocks, and A. Coppen

Subjects
Suicide Prevention, Pediatrics, medicine.medical_specialty, Bipolar Disorder, Lithium (medication), Population, Lithium Carbonate, Recurrence, Cause of Death, medicine, Humans, Risk factor, Psychiatry, education, Excess mortality, Depressive Disorder, education.field_of_study, Wales, business.industry, Incidence, medicine.disease, Suicide, Psychiatry and Mental health, Clinical Psychology, Cross-Sectional Studies, Increased risk, Mood, England, Psychotic Disorders, Mood disorders, Relative risk, business, Follow-Up Studies, medicine.drug
Abstract

Numerous follow-up studies have shown that patients with mood disorders who do not receive prophylactic medication are at increased risk of death, particularly from suicide. After 11 years follow-up we compared the mortality of 103 patients attending a lithium clinic with that expected on the basis of age/sex/year-specific rates for England and Wales. Only 10 patients died during the study, although the expected number of deaths was 18.31 ( P = 0.052, two-tailed) and no deaths from suicide were observed. After correcting for the prevalence of mood disorder in the general population, the relative risk was 0.60 (95% CI 0.29-1.12) which suggests that lithium reverses the excess mortality associated with recurrent mood disorders, including that from suicide.

Published
1991

6. Treating refractory depression

Author

H, Standish-Barry

Subjects
Depressive Disorder, Bipolar Disorder, Dose-Response Relationship, Drug, Chronic Disease, Humans, Combined Modality Therapy, Antidepressive Agents, Aged, Frontal Lobe, Psychosurgery
Published
1990

7. Ventricular Size and CSF Transmitter Metabolite Concentrations in Severe Endogenous Depression

Author

P K Bridges, A. S. Hale, H. M. A. S. Standish-Barry, Nick Bouras, and J. R. Bartlett

Subjects
Adult, Male, medicine.medical_specialty, Metabolite, Cerebral Ventricles, Ventricular CSF, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Humans, Medicine, cardiovascular diseases, 030212 general & internal medicine, Neurotransmitter, Aged, Depressive Disorder, Neurotransmitter Agents, Ventricular size, business.industry, Tryptophan, Hydroxyindoleacetic Acid, Middle Aged, 030227 psychiatry, Psychiatry and Mental health, Endocrinology, chemistry, Free tryptophan, Ventricular enlargement, Endogenous depression, cardiovascular system, Female, business
Abstract

The relationship between neurotransmitter metabolite concentrations and measurements of ventricular size on CAT scans and pneumoencephalographs was investigated in 15 patients with severe affective disorder. An association was identified between reduced levels of plasma free tryptophan and ventricular enlargement and also between raised ventricular CSF levels of 5 HIAA and ventricular enlargement.

Published
1986

8. The relationship of concurrent benzodiazepine administration to seizure duration in ECT

Author

H. H. A. S. Standish-Barry, V. Deacon, and R. P. Snaith

Subjects
Oral dose, Adult, Male, Time Factors, medicine.drug_class, medicine.medical_treatment, behavioral disciplines and activities, Electroconvulsive therapy, Oral administration, mental disorders, medicine, Humans, Electroconvulsive Therapy, Depression (differential diagnoses), Benzodiazepine, Chemotherapy, Depressive Disorder, Diazepam, Middle Aged, medicine.disease, Combined Modality Therapy, Psychiatry and Mental health, Anesthesia, Major depressive disorder, Female, Psychology, medicine.drug
Abstract

The relationship of concurrent benzodiazepine administration to seizure duration in ECT was examined. Administration of a standard oral dose of 10 mg diazepam to a series of patients suffering from major depressive disorder produced a significant reduction in men seizure length during ECT compared to length of ECT-induced seizure in those patients when they were benzodiazepine free. This finding is discussed.

Published
1985

Catalog

Books, media, physical & digital resources
See catalog results